Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06692699

The A.R.R.E.S.T.® Spectacle Film Study

Spectacle Films Utilising A.R.R.E.S.T.® Technology for Slowing Myopia Progression in Vietnamese Children: A Prospective, Controlled, Randomised Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
nthalmic Pty Ltd · Network
Sex
All
Age
6 Years – 14 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if spectacle films using Active Reconfiguration in Retinal Encoding of Spatio-Temporal (A.R.R.E.S.T.®) signal technology works to slow down the rate of myopia progression compared to single vision spectacle lenses in myopic children. The main questions it aims to answer are: Do spectacle films using A.R.R.E.S.T.® technology slow down the rate of axial length growth? Do spectacle films using A.R.R.E.S.T.® technology slow down the rate of increase in myopic refractive error? Researchers will compare spectacle films using A.R.R.E.S.T.® technology to a single vision spectacle lens. Participants will: Be randomly allocated to wear either spectacle lenses using A.R.R.E.S.T.® technology or single vision spectacle lenses. Visit the clinic on seven occasions over a 12 month period.

Detailed description

The aim of this clinical trial is to compare the rate of myopia progression as measured by change from the Dispensing visit (up to 40 days from Baseline), in axial length and the change from Baseline in the spherical equivalent cycloplegic autorefraction between a spectacle film design using A.R.R.E.S.T.® technology (test) and a single vision spectacle lens (control). Myopic children (6-14 years of age) will be randomly allocated to wear either test or control. The overall trial duration, including follow-up period, is expected to be approximately 18 months. Each participant's duration is expected to be approximately 12 months. The visits are Baseline, Dispensing, 1 month, 3 months, 6 months, 9 months, and 12 months. All procedures performed at these visits are standard, non invasive clinical tests.

Conditions

Interventions

TypeNameDescription
DEVICESingle vision spectacle lensStandard single vision spectacle lens
DEVICEA.R.R.E.S.T. spectacle filmA.R.R.E.S.T. spectacle film

Timeline

Start date
2025-04-12
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2024-11-18
Last updated
2025-04-17

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT06692699. Inclusion in this directory is not an endorsement.